Immediate Postpartum Insertion of Contraceptive Intrauterine Devices

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

In this randomized trial, investigators intend to determine the expulsion and discontinuation rate of immediate postpartum intrauterine devices in the patient population of the University of Oklahoma Women's Healthcare Specialists Clinic (OUWHSC).

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Oklahoma
• Treatments: Contraceptive Agents; Levonorgestrel

Criteria

Inclusion Criteria:

• 18 years or older

• desire an intrauterine device as postpartum contraception

• want to avoid pregnancy for at least 1 year

• are currently pregnant

• desire immediate postpartum IUD insertion.

Exclusion Criteria:

• known uterine or cervical anomaly

• untreated cervical infection

• untreated cervical infection

• pelvic infection within 3 months of the study

• recent (within last 3 months) or active intrauterine infection

• genital bleeding of unknown etiology

• history of postpartum or postabortal sepsis

• cervical cancer or carcinoma in suit

• plan to leave Tulsa area within 10 weeks postpartum

• allergy to device ingredients